Manuscripts
Showing 1554 manuscripts.
Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age
Citation
Ellen G. Chadwick , Mutsa Bwakura-Dangarembizi, Carolyn Bolton Moore, Pearl Samson, Stephen A Spector, Nahida Chakhtoura, Patrick Jean-Philippe, Lisa Frenkel, Bonnie Zimmer, Alex Benns, Jennifer Libous, Edmund V. Capparelli, Mina Nikanjam, Lana Tran. Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age. AIDS. 2022. 36: 525-532. PMID: 34873089Year
2022
Journal
AIDS
Study
P1070
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants
Citation
Daisy Ko, Annie Wong-on-Wing, Ingrid A. Beck, Sheila M. Styrchak, Patricia DeMarrais, Camlin Tierney, Lynda Stranix-Chibanda, Patricia M. Flynn, Taha E. Taha, Maxensia Owor, Mary Glenn Fowler, Lisa M. Frenkel, Ceejay L. Boyce, Tatiana Sils. Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants. Clinical Infectious Diseases. 2022. 74: 2001-2009. PMID: 34467974Year
2022
Journal
Clinical Infectious Diseases
Study
1077FF, 1077BF
Coordination of inflammatory responses in children with perinatally acquired HIV infection
Citation
Patricia A. Sirois, Grace Montepiedra, Jennifer Canniff, Allison Agwu, Michael J. Boivin, Suad Kapetanovic, Mark J. Abzug, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network, Adriana Weinberg, Mark J. Giganti. Coordination of inflammatory responses in children with perinatally acquired HIV infection. AIDS. 2022. 36: 1117-1127. PMID: 35442223Year
2022
Journal
AIDS
Study
P1104s, P1060
Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States
Citation
Betsy D. Kennard, IMPAACT 2002 team, Graham J. Emslie, Miriam Chernoff, Sarah Buisson, Kathryn Lypen, Laura B. Whiteley, Shirley Traite, Chelsea Krotje, Kevin Knowles, Ellen Townley, Jaime Deville, Megan Wilkins, Dan Reirden, Mary Paul, Larry K. Brown, Christy Beneri, Kristin Baltrusaitis, David E. Shapiro. Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 296-304. PMID: 35839439Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2002
Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair
Citation
Osamuedeme J. Odiase, Peter Bacchetti, Hideaki Okochi, Regina Tallerico, Vongai M. Chanaiwa, Tichaona Vhembo, Mercy T. Mutambanengwe-Jacob, Alexander Louie, Tsungai Chipato, Monica Gandhi, Lynda Stranix-Chibanda, IMPAACT PROMISE Study Team, Teacler G. Nematadzira, Pamela M. Murnane. Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 237-241. PMID: 35952357Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF
Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
Citation
Barbara Laughton, Paul E Palumbo, Michael J Boivin, Mark F. Cotton, Mutsa Bwakura-Dangarembizi, Avy Violari, Itziar Familiar-Lopez, Linda Barlow-Mosha, Portia Kamthunzi, Katie Mccarthy, Patrick Jean-Philippe, Lee Fairlie, Miriam Chernoff. Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa. Frontiers in Pediatrics. 2022. 10: 899002. PMID: 35989995Year
2022
Journal
Frontiers in Pediatrics
Study
P1104s
Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.
Citation
Sikorskii A, Atuhaire P, Ogwang LW, Mutebe A, Katumbi C, Maliwichi L, Familiar I, Taha T, Boivin MJ, PROMISE-NEURODEV study team, Fowler MG, Aizire J. Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.. AIDS. 2022. 36: 573-582. PMID: 34750297Year
2022
Journal
AIDS
High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis
Citation
Hughes MD, Shah NS, Upton C, Gupta A, Narunsky K, Hesseling AC, Mendoza-Ticona A, ACTG A5300/IMPAACT 2003/PHOENix Feasibility Study Team, Khajenoori S, Gonzales P, Badal-Faesen S, Shenje J, Omoz-Oarhe A, Rouzier V, Garcia-Prats AJ, Demers AM, Naini L, Smith E, Kim S, Churchyard G, Wu X, Swindells S. High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis. Pediatric Infectious Disease Journal. 2022. 41: 194-202. PMID: 35239624Year
2022
Journal
Pediatric Infectious Disease Journal
Study
IMPAACT 2003/ACTG 5300
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.
Citation
Penn-Nicholson A, Toefy A, Erasmus M, Hanekom WA, Scriba TJ, Lai RPJ, Marais S, Fletcher HA, Meintjes G, Wilkinson RJ, Cotton MF, Pahwa S, Cameron MJ, Nemes E, Mbandi SK, Painter H. Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.. European Journal of Immunology. 2022. 52: 1112-1119. PMID: 35398886Year
2022
Journal
European Journal of Immunology
Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial
Citation
Jessica P. Liu, Andrew Wiznia, Kathryn P. Gray, IMPAACT P1093 Team, Kathleen George, Nicole Montañez, Stephanie Popson, Ann M. Buchanan, Mattie Bartlett, Dale Dayton, Patricia Anthony, Cynthia Brothers, Cynthia Vavro, Rajendra Singh, Lucy Koech, Tichaona Vhembo, Theodore D. Ruel, Rohan Hazra, Edward P. Acosta, Ellen Townley. Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial. Lancet HIV. 2022. PMID: 35489377Year
2022
Journal
Lancet HIV
Study
P1093